Zhou Liang, Wei Xin, Sun Wen-Jin, Liu Qiang, Jian Zhong-Yu, Li Hong, Wang Kun-Jie
1 Department of Urology, West China Hospital, Sichuan University , Chengdu, Sichuan, P.R. China .
2 The Second Xiangya Hospital, Central South University , Changsha, P.R. China .
J Endourol. 2015 Aug;29(8):855-63. doi: 10.1089/end.2014.0878. Epub 2015 Mar 26.
To compare the clinical efficacy and safety of selective vs hilar clamping during minimally invasive partial nephrectomy (PN).
Studies comparing the effect and safety of selective versus hilar clamping during PN were identified by a systematic search using MEDLINE and EMBASE from January 2000 to November 2014. Quality of the selected studies was assessed according to the Newcastle-Ottawa Scale (NOS).
A total of seven retrospective studies were included. No significant differences were observed between the two groups in age, body mass index, tumor size, pre-estimated glomerular filtration rate (eGFR), operative time, and length of stay. The selective clamping group had greater estimated blood loss (P<0.01) but similar blood transfusion rate (P=0.78) compared with the hilar clamping group. There were no significant differences between the two groups in terms of urinary leaks, overall complication rate, and positive margin rate. Patients who underwent selective clamping had a lower change in eGFR (mean difference [MD]: 13.95; 95% CI 8.85 to 19.05; P<0.01) and a lower percent change in eGFR (MD: 18.51; 95% CI 14.18 to 22.84; P<0.01) at 1 week. Combined results from two studies showed a trend toward a lower percent change in eGFR at 3 months (MD: 5.47; 95% CI -0.28 to 11.22; P=0.06). At 6 months, two studies showed no significant differences in percent change of renal function between the two groups (MD: 16.85; 95% CI -10.47 to 44.16; P=0.23).
Although selective clamping resulted in greater estimated blood loss, it provided comparable perioperative safety and superior short-term renal function preservation. The advantage of selective clamping in preservation of intermediate-term renal function remains to be evaluated in the future, however. There is a need for properly designed studies to confirm our founding.
比较微创部分肾切除术(PN)中选择性肾蒂阻断与肾门阻断的临床疗效及安全性。
通过系统检索MEDLINE和EMBASE数据库(2000年1月至2014年11月),确定比较PN中选择性肾蒂阻断与肾门阻断的疗效及安全性的研究。根据纽卡斯尔-渥太华量表(NOS)评估所选研究的质量。
共纳入7项回顾性研究。两组在年龄、体重指数、肿瘤大小、预估肾小球滤过率(eGFR)、手术时间和住院时间方面未观察到显著差异。与肾门阻断组相比,选择性肾蒂阻断组估计失血量更多(P<0.01),但输血率相似(P=0.78)。两组在尿漏、总体并发症发生率和切缘阳性率方面无显著差异。接受选择性肾蒂阻断的患者在术后1周时eGFR的变化更低(平均差值[MD]:13.95;95%可信区间8.85至19.05;P<0.01),eGFR的百分比变化也更低(MD:18.51;95%可信区间14.18至22.84;P<0.01)。两项研究的综合结果显示,术后3个月时eGFR百分比变化有降低趋势(MD:5.47;95%可信区间-0.28至11.22;P=0.06)。在术后6个月时,两项研究显示两组肾功能百分比变化无显著差异(MD:16.85;95%可信区间-10.47至44.16;P=0.23)。
虽然选择性肾蒂阻断导致估计失血量更多,但它提供了相当的围手术期安全性和更好的短期肾功能保留。然而,选择性肾蒂阻断在中期肾功能保留方面的优势仍有待未来评估。需要进行设计合理的研究来证实我们的发现。